Naveed Sattar on early, large-scale weight loss & the future of type 2 diabetes care, Laurent Azoulay on GLP-1s & the risk for optic neuropathy, plus a classic edition of "Rapid Exchange."

Welcome to the latest episode (May 2026) of Diabetes Care "On Air"—a new and different way to bring the research published in Diabetes Care to life. Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they discuss the latest and greatest content in the May 2026 issue of Diabetes Care and beyond.

4:45 Alice welcomes Naveed Sattar, MBChB, PhD, Professor of Cardiometabolic Medicine at the University of Glasgow. He is a co-author on the article "Why Early, Large-scale Weight Loss Is the Future of Type 2 Diabetes Care," available for free at doi.org/10.2337/dci25-0069.

30:05 Mike speaks with ​​Laurent Azoulay, PhD, Associate Professor in the Department of Epidemiology, Biostatistics and Occupational Health and Gerald Bronfman Department of Oncology, McGill University in Montreal, Canada. He is senior author on the article "Glucagon-Like Peptide 1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients With Type 2 Diabetes," available for free at doi.org/10.2337/dc25-2577.

36:15 In this month's "Rapid Exchange" segment, Alice and Mike wrap up the episode by reviewing several interesting articles in the May 2025 issue of Diabetes Care. Studies highlighted in this segment include:

• Ganeshalingam et al. Semaglutide Effects on Insulin Sensitivity and β-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial With Semaglutide 1.0 mg Weekly doi.org/10.2337/dc25-2041

• Mital et al. Everyone or Just Some? Cost-Effectiveness of General Population Versus Targeted Screening Strategies for Type 1 Diabetes in Canada doi.org/10.2337/dc25-2248

• Weiskorn et al. Hypercholesterolemia and Lipid-Lowering Therapy in Children and Adolescents With Type 1 Diabetes: Do We Implement Current Guidelines? doi.org/10.2337/dc25-2459

• Ziegler et al. Effect of High-Dose Oral Insulin in Children With Stage 1 Type 1 Diabetes: The Fr1da Insulin Intervention Randomized Controlled Trial doi.org/10.2337/dc25-2818

• Harjutsalo et al. Shrunken Pore Syndrome and Risk of Cardiovascular Disease and All-Cause Mortality in Individuals With Type 1 Diabetes With and Without Albuminuria doi.org/10.2337/dc25-2987

• Maher et al, Screening for Diabetes and Prediabetes in Cystic Fibrosis Using a Nonfasting 50-Gram 1-Hour Oral Glucose Challenge Test doi.org/10.2337/dc25-2806

To learn more about Diabetes Care, please visit diabetesjournals.org/care. Interested in submitting cover art to the journal? Please visit https://diabetesjournals.org/care/pages/submit_a_cover_image.